WHO ICTRP trial
Efficacy and safety evaluation of probiotic in improving depressive and anxious…
ChiCTR2300068235 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300068235 |
|---|---|
| Public title | Efficacy and safety evaluation of probiotic in improving depressive and anxious symptoms of depression patients with reduced substance T: a randomized, double-blind, placebo-controlled clinical trial |
| Scientific title | Efficacy and safety evaluation of probiotic in improving depressive and anxious symptoms of depression patients with reduced substance T: a randomized, double-blind, placebo-controlled clinical trial |
| Primary sponsor | The Second Affiliated Hospital of Anhui Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | depression |
| Interventions | control group:placebo;Treatment group:Microbial live bacteria |
| Registration date | Feb 10, 2023 |
| Target size | control group:148;Treatment group:148 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: